Intervention Review

Bisphosphonates and other bone agents for breast cancer

  1. Matthew HF Wong1,
  2. Martin R Stockler2,
  3. Nick Pavlakis1,*

Editorial Group: Cochrane Breast Cancer Group

Published Online: 15 FEB 2012

Assessed as up-to-date: 30 APR 2011

DOI: 10.1002/14651858.CD003474.pub3


How to Cite

Wong MHF, Stockler MR, Pavlakis N. Bisphosphonates and other bone agents for breast cancer. Cochrane Database of Systematic Reviews 2012, Issue 2. Art. No.: CD003474. DOI: 10.1002/14651858.CD003474.pub3.

Author Information

  1. 1

    Royal North Shore Hospital, Department of Medical Oncology, Sydney, NSW, Australia

  2. 2

    University of Sydney, NHMRC Clinical Trials Centre and Sydney Cancer Centre, Camperdown, NSW, Australia

*Nick Pavlakis, Department of Medical Oncology, Royal North Shore Hospital, Pacific Highway, Sydney, NSW, 2065, Australia. pavlakis@med.usyd.edu.au.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 15 FEB 2012

SEARCH

  1. Current Version

    Bisphosphonates and other bone agents for breast cancer

    Matthew HF Wong, Martin R Stockler and Nick Pavlakis

    Article first published online: 15 FEB 2012 | DOI: 10.1002/14651858.CD003474.pub3

Previous versions of this article and their online publication dates

  1. Version 2

    Bisphosphonates for breast cancer

    Nick Pavlakis, Robert L Schmidt and Martin R Stockler

    Article first published online: 20 JUL 2005 | DOI: 10.1002/14651858.CD003474.pub2

  2. Version 1

    Bisphosphonates for breast cancer

    N Pavlakis and M Stockler

    Article first published online: 21 JAN 2002 | DOI: 10.1002/14651858.CD003474